Health
WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection – World Health Organization
WHO today recommended that the dapivirine vaginal ring (DPV-VR) may be offered as an additional prevention choice for women at substantial risk[1] of HIV infection…
WHO today recommended that the dapivirine vaginal ring (DPV-VR) may be offered as an additional prevention choice for women at substantial risk[1] of HIV infection as part of combination prevention approaches.
The DPV-VR is a female-initiated option to reduce the risk of HIV infection. To properly use the ring, it must be worn inside the vagina for a period of 28 days, after which it should be replaced by a new ring. The ring is made of silicone and is easy
to bend and insert. The ring works by…
-
Noosa News15 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General13 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News14 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Business16 hours agoSolid superannuation gains continue to roll in